Pfizer and BioNTech are expected to seek authorization from the FDA for their COVID-19 shot for children younger than 5 as early as Feb. 8, which could make it the first vaccine available for the age group by the end of February, The Washington Post reported Jan. 31.
Read the full post on Becker's Hospital Review - Healthcare News
